Bios Equity COF, LP

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Bios Equity COF, LP's trades of Actuate Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-30 2025-06-27
B Purchase
78,862 +19.5%
309.06
US$1,988,617 		78,862 +19.5% 309.06 US$1,988,617
2024-08-14 2024-08-14
S Sale
29,739 +38.1%
232.89
US$2,420,911 		29,739 +38.1% 232.89 US$2,420,911
2024-08-14 2024-08-14
S Sale
86,113 -39.5%
200.73
US$1,920,136 		86,113 -39.5% 200.73 US$1,920,136
2024-08-14 2024-08-14
S Sale
5,314 -1.7%
9.00
US$47,826 		5,314 -1.7% 9.00 US$47,826
2024-08-14 2024-08-14
B Purchase
125,000 +inf%
8.00
US$1,000,000 		125,000 +inf% 8.00 US$1,000,000
2024-08-14 2024-08-14
B Purchase
375,000 +42.4%
8.00
US$3,000,000 		375,000 +42.4% 8.00 US$3,000,000